# Marker Therapeutics, Inc.: Form 8-K, filed May 4, 2026

- Company: [Marker Therapeutics, Inc.](/companies/mrkr.md) (CIK 1094038)
- Form: 8-K
- Filed: 2026-05-04
- Accepted by EDGAR: May 4, 2026, 20:30 ET
- Period: 2026-05-01
- Accession: 0001104659-26-054940
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/tm2613511d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/tm2613511d1_8k.htm

Filed May 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-054940. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.